Literature DB >> 19246257

Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues.

Shweta R Urva1, Beom Soo Shin, Victor C Yang, Joseph P Balthasar.   

Abstract

A sensitive high performance liquid chromatography method (HPLC) has been developed for the quantification of doxorubicin in mouse plasma and tissues. Samples of serum or tissue homogenates, 20 microl, were analyzed following a single step protein precipitation using perchloric acid (35%, v/v). Doxorubicin was separated from the internal standard, daunorubicin, on a Zorbax 300SB C(18) column at 35 degrees C. Mobile phase was comprised of acetonitrile and water (25:75) containing 0.1% triethylamine, and was adjusted to pH 3 with phosphoric acid. Peaks eluting from the column were detected with a fluorescence detector with excitation and emission wavelengths of 480 and 560 nm, respectively. Standard curves were linear in the range 5-1000 ng/ml, and correlation coefficients were typically greater than 0.999. Intra-assay recoveries ranged from 94.7 to 99.9%, and inter-assay recoveries were in the range of 95.2-101%. The associated coefficient of variation (CV) was less than 10% in all cases. The method was successfully applied to investigate doxorubicin plasma pharmacokinetics and tissue distribution in athymic Fox(nu) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246257     DOI: 10.1016/j.jchromb.2009.02.018

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

1.  Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.

Authors:  Fan Zhou; Juan Hu; Jiang-Hua Shao; Shu-Bing Zou; Shun-Li Shen; Zhi-Qiang Luo
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-27       Impact factor: 4.553

2.  In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics.

Authors:  Tian Yu; Dallin Hubbard; Abhijit Ray; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

3.  Tandem laser-induced fluorescence and mass spectrometry detection for high-performance liquid chromatography analysis of the in vitro metabolism of doxorubicin.

Authors:  Joseph B Katzenmeyer; Christopher V Eddy; Edgar A Arriaga
Journal:  Anal Chem       Date:  2010-10-01       Impact factor: 6.986

4.  Simple and rapid monitoring of doxorubicin using streptavidin-modified microparticle-based time-resolved fluorescence immunoassay.

Authors:  Junyu Liang; Zhigao Zhang; Hui Zhao; Shanhe Wan; Xiangming Zhai; Jianwei Zhou; Rongliang Liang; Qiaoting Deng; Yingsong Wu; Guanfeng Lin
Journal:  RSC Adv       Date:  2018-04-25       Impact factor: 4.036

5.  Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma.

Authors:  Jonás Samuel Pérez-Blanco; Dolores Santos-Buelga; María Del Mar Fernández de Gatta; Jesús María Hernández-Rivas; Alejandro Martín; María José García
Journal:  Br J Clin Pharmacol       Date:  2016-09-06       Impact factor: 4.335

6.  Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia.

Authors:  Gerald J Fetterly; Urvi Aras; Deepika Lal; Michael Murphy; Patricia D Meholick; Eunice S Wang
Journal:  AAPS J       Date:  2013-04-03       Impact factor: 4.009

7.  Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer.

Authors:  Jia Lin; Yan Yu; Sarah Shigdar; Ding Zhi Fang; Jun Rong Du; Ming Q Wei; Andrew Danks; Ke Liu; Wei Duan
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  A Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats.

Authors:  Marjan Daeihamed; Azadeh Haeri; Simin Dadashzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  HPLC Method Development for Quantification of Doxorubicin in Cell Culture and Placental Perfusion Media.

Authors:  Mansi Shah; Luke Bourner; Shariq Ali; Sanaalarab Al-Enazy; Menatallah M Youssef; Morgan Fisler; Erik Rytting
Journal:  Separations       Date:  2018-01-24

10.  Folate-Targeted PEGylated Magnetoliposomes for Hyperthermia-Mediated Controlled Release of Doxorubicin.

Authors:  Emílio R Cintra; Tacio G Hayasaki; Ailton A Sousa-Junior; Artur C G Silva; Marize C Valadares; Andris F Bakuzis; Sebastião A Mendanha; Eliana M Lima
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.